Long-term follow-up on Cushing disease patient after transsphenoidal surgery
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cushing disease is caused by excessive adrenocorticotropic hormone (ACTH) production by the pituitary adenoma. Transsphenoidal surgery is its first-line treatment. The incidence of Cushing disease in children and adolescents is so rare that long-term prognoses have yet to be made in most cases. We followed- up on a 16-year-old male Cushing disease patient who presented with rapid weight gain and growth retardation. The laboratory findings showed increased 24-hour urine free cortisol and lack of overnight cortisol suppression by low- dose dexamethasone test. The serum cortisol and 24-hour urine free cortisol, by high-dose dexamethasone test, also showed a lack of suppression, and a bilateral inferior petrosal sinus sampling suggested lateralization of ACTH secretion from the right-side pituitary gland. However, after a right hemihypophysectomy by the transsphenoidal approach, the 24-hour urine free cortisol levels were persistently high. Thus the patient underwent a total hypophysectomy, since which time he has been treated with hydrocortisone, levothyroxine, recombinant human growth hormone, and testosterone enanthate. Intravenous bisphosphonate for osteoporosis had been administered for three years. At his current age of 26 years, his final height had attained the target level range; his bone mineral density was normal, and his pubic hair was Tanner stage 4. This report describes the long-term treatment course of a Cushing disease patient according to growth profile, pubertal status, and responses to hormone replacement therapy. The clinical results serve to emphasize the importance of growth optimization, puberty, and bone health in the treatment management of Cushing disease patients who have undergone transsphenoidal surgery.
Abstract
Cushing disease is caused by excessive adrenocorticotropic hormone (ACTH) production by the pituitary adenoma. Transsphenoidal surgery is its first-line treatment. The incidence of Cushing disease in children and adolescents is so rare that long-term prognoses have yet to be made in most cases. We followed- up on a 16-year-old male Cushing disease patient who presented with rapid weight gain and growth retardation. The laboratory findings showed increased 24-hour urine free cortisol and lack of overnight cortisol suppression by low- dose dexamethasone test. The serum cortisol and 24-hour urine free cortisol, by high-dose dexamethasone test, also showed a lack of suppression, and a bilateral inferior petrosal sinus sampling suggested lateralization of ACTH secretion from the right-side pituitary gland. However, after a right hemihypophysectomy by the transsphenoidal approach, the 24-hour urine free cortisol levels were persistently high. Thus the patient underwent a total hypophysectomy, since which time he has been treated with hydrocortisone, levothyroxine, recombinant human growth hormone, and testosterone enanthate. Intravenous bisphosphonate for osteoporosis had been administered for three years. At his current age of 26 years, his final height had attained the target level range; his bone mineral density was normal, and his pubic hair was Tanner stage 4. This report describes the long-term treatment course of a Cushing disease patient according to growth profile, pubertal status, and responses to hormone replacement therapy. The clinical results serve to emphasize the importance of growth optimization, puberty, and bone health in the treatment management of Cushing disease patients who have undergone transsphenoidal surgery.
참고문헌 (17)
- Carpenter PC, "Cushing's syndrome: update of diagnosis and management", Mayo Clin Proc, 61, pp.49~58 (1986)
- Magiakou MA, "Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies", J Endocrinol Invest, 25, pp.181~194 (2002)
- Storr HL, "Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances", Trends Endocrinol Metab, 18, pp.167~174 (2007)
- Savage MO, "Pediatric Cushing's disease: management issues", Indian J Endocrinol Metab, 16(Suppl 2), pp.S171~S175 (2012)
- Peters CJ, "Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease", Horm Res, 68, pp.231~235 (2007)
- Magiakou MA, "Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy", N Engl J Med, 331, pp.629~636 (1994)
- Massoud AF, "Transsphenoidal surgery for pituitary tumours", Arch Dis Child, 76, pp.398~404 (1997)
- Greulich WW, "Radiographic atlas of skeletal development of the hand and wrist" (1959), Stanford University Press
- Di Somma C, "Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease", Clin Endocrinol, 56, pp.153~158 (2002)
- Tierney TS, "Cushing’s disease", pp.121~141 (2011), Endocrine Updates
- Atkinson AB, "Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance", Clin Endocrinol, 63, pp.549~559 (2005)
- Honegger J, "Contemporary microsurgical concept for the treatment of Cushing's disease: endocrine outcome in 83 consecutive patients", Clin Endocrinol, 76, pp.560~567 (2012)
- Patil CG, "Late recurrences of Cushing's disease after initial successful transsphenoidal surgery", J Clin Endocrinol Metab, 93, pp.358~362 (2008)
- Varadhan L, "Cushing's disease: establishing the diagnosis and management approach", J Assoc Physicians India, 61, pp.278~280 (2013)
- Omori N, "Rational, effective metyrapone treatment of ACTHindependent bilateral macronodular adrenocortical hyperplasia (AIMAH)", Endocr J, 48, pp.665~669 (2001)
- Etxabe J, "Morbidity and mortality in Cushing's disease: an epidemiological approach", Clin Endocrinol, 40, pp.479~484 (1994)
- Sonino N, "Psychosomatic aspects of Cushing's syndrome", Rev Endocr Metab Disord, 11, pp.95~104 (2010)